Back to search results

ePNa Clinical Decision Support for Urgent Care Pneumonia

This study is testing a new electronic tool called ePNa-CheXED in urgent care clinics in Utah. ePNa-CheXED combines an existing tool (ePNa) that helps doctors treat pneumonia with an artificial intelligence (AI) model called CheXED. CheXED can quickly analyze chest images to help diagnose pneumonia. The goal is to see how well ePNa-CheXED is used by doctors and how it affects the urgent care environment. You may be eligible to participate if you are 12 years or older and have pneumonia, confirmed by a specific medical code or related conditions. Doctors and advanced practice clinicians working in 4 Utah Valley Instacares are also part of this study. The study's current status is unclear.

Study design
This is an interventional study, meaning participants will receive an intervention. It aims to enroll 4000 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study will measure ePNa utilization and its impact through the end of the study, which is year 3.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04606849

Adaptation and Pilot Implementation of ePNa Clinical Decision Support for Utah Urgent Care Clinics

Recruiting
NAAges 12+InterventionalHealth services
Intermountain Health Care, Inc.
~4,000 participants
Updated 2024-08-26 on ClinicalTrials.gov
What's tested:Physician SurveyePNa-CheXED

At a glance

Recruiting sites
6 of 12 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
ePNa utilization and impact on the UCC clinical environment
Measured over through study completion, year 3 of the study

Conditions

Pneumonia

Explore related trials

Pneumonia

Where it's being run

12 sites across 1 states
Utah12

Study leadership

  • Nathan Dean, MD · PRINCIPAL_INVESTIGATOR · Intermountain Health Care, Inc.

Who to contact

Valerie Aston
[email protected]
801-507-4606
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

All patients ≥ 12 years of age with pneumonia: defined by the J-18.X pneumonia code or acute respiratory failure or sepsis with secondary pneumonia codes

Exclusion

Patients without radiographic confirmation of pneumonia
Subsequent episodes of pneumonia within 12 months (so as not to over-represent patients with recurrent pneumonia caused by recurrent aspiration or structural lung disease).

What this trial measures

  • ePNa utilization and impact on the UCC clinical environmentthrough study completion, year 3 of the study

    Frequency of clinicians' disagreement with different ePNa recommendations will be monitored along with a tally of the structured reasons for disagreement entered by clinicians into ePNa.